Conformational dynamics of the human serotonin transporter during substrate and drug binding

Ingvar R Möller; Marika Slivacka; Anne Kathrine Nielsen; Søren G F Rasmussen; Ulrik Gether; Claus J Loland; Kasper D Rand

doi:10.1038/s41467-019-09675-z

Conformational dynamics of the human serotonin transporter during substrate and drug binding

Ingvar R Möller, Marika Slivacka, Anne Kathrine Nielsen, Søren G F Rasmussen, Ulrik Gether, Claus J Loland, Kasper D Rand

19 Citations (Scopus)

24 Downloads (Pure)

Abstract

The serotonin transporter (SERT), a member of the neurotransmitter:sodium symporter family, is responsible for termination of serotonergic signaling by re-uptake of serotonin (5-HT) into the presynaptic neuron. Its key role in synaptic transmission makes it a major drug target, e.g. for the treatment of depression, anxiety and post-traumatic stress. Here, we apply hydrogen-deuterium exchange mass spectrometry to probe the conformational dynamics of human SERT in the absence and presence of known substrates and targeted drugs. Our results reveal significant changes in dynamics in regions TM1, EL3, EL4, and TM12 upon binding co-transported ions (Na+/K+) and ligand-mediated changes in TM1, EL3 and EL4 upon binding 5-HT, the drugs S-citalopram, cocaine and ibogaine. Our results provide a comprehensive direct view of the conformational response of SERT upon binding both biologically relevant substrate/ions and ligands of pharmaceutical interest, thus advancing our understanding of the structure-function relationship in SERT.

Original language	English
Article number	1687
Journal	Nature Communications
Volume	10
Issue number	1
ISSN	2041-1723
DOIs	https://doi.org/10.1038/s41467-019-09675-z
Publication status	Published - 1 Dec 2019

Access to Document

10.1038/s41467-019-09675-zLicence: CC BY

s41467-019-09675-zFinal published version, 2.76 MBLicence: CC BY

Cite this

@article{93c018ccf9b44ed3994613c2d8f8c6fb,

title = "Conformational dynamics of the human serotonin transporter during substrate and drug binding",

abstract = "The serotonin transporter (SERT), a member of the neurotransmitter:sodium symporter family, is responsible for termination of serotonergic signaling by re-uptake of serotonin (5-HT) into the presynaptic neuron. Its key role in synaptic transmission makes it a major drug target, e.g. for the treatment of depression, anxiety and post-traumatic stress. Here, we apply hydrogen-deuterium exchange mass spectrometry to probe the conformational dynamics of human SERT in the absence and presence of known substrates and targeted drugs. Our results reveal significant changes in dynamics in regions TM1, EL3, EL4, and TM12 upon binding co-transported ions (Na+/K+) and ligand-mediated changes in TM1, EL3 and EL4 upon binding 5-HT, the drugs S-citalopram, cocaine and ibogaine. Our results provide a comprehensive direct view of the conformational response of SERT upon binding both biologically relevant substrate/ions and ligands of pharmaceutical interest, thus advancing our understanding of the structure-function relationship in SERT.",

author = "M{\"o}ller, {Ingvar R} and Marika Slivacka and Nielsen, {Anne Kathrine} and Rasmussen, {S{\o}ren G F} and Ulrik Gether and Loland, {Claus J} and Rand, {Kasper D}",

year = "2019",

month = dec,

day = "1",

doi = "10.1038/s41467-019-09675-z",

language = "English",

volume = "10",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "nature publishing group",

number = "1",

}

TY - JOUR

T1 - Conformational dynamics of the human serotonin transporter during substrate and drug binding

AU - Möller, Ingvar R

AU - Slivacka, Marika

AU - Nielsen, Anne Kathrine

AU - Rasmussen, Søren G F

AU - Gether, Ulrik

AU - Loland, Claus J

AU - Rand, Kasper D

PY - 2019/12/1

Y1 - 2019/12/1

N2 - The serotonin transporter (SERT), a member of the neurotransmitter:sodium symporter family, is responsible for termination of serotonergic signaling by re-uptake of serotonin (5-HT) into the presynaptic neuron. Its key role in synaptic transmission makes it a major drug target, e.g. for the treatment of depression, anxiety and post-traumatic stress. Here, we apply hydrogen-deuterium exchange mass spectrometry to probe the conformational dynamics of human SERT in the absence and presence of known substrates and targeted drugs. Our results reveal significant changes in dynamics in regions TM1, EL3, EL4, and TM12 upon binding co-transported ions (Na+/K+) and ligand-mediated changes in TM1, EL3 and EL4 upon binding 5-HT, the drugs S-citalopram, cocaine and ibogaine. Our results provide a comprehensive direct view of the conformational response of SERT upon binding both biologically relevant substrate/ions and ligands of pharmaceutical interest, thus advancing our understanding of the structure-function relationship in SERT.

AB - The serotonin transporter (SERT), a member of the neurotransmitter:sodium symporter family, is responsible for termination of serotonergic signaling by re-uptake of serotonin (5-HT) into the presynaptic neuron. Its key role in synaptic transmission makes it a major drug target, e.g. for the treatment of depression, anxiety and post-traumatic stress. Here, we apply hydrogen-deuterium exchange mass spectrometry to probe the conformational dynamics of human SERT in the absence and presence of known substrates and targeted drugs. Our results reveal significant changes in dynamics in regions TM1, EL3, EL4, and TM12 upon binding co-transported ions (Na+/K+) and ligand-mediated changes in TM1, EL3 and EL4 upon binding 5-HT, the drugs S-citalopram, cocaine and ibogaine. Our results provide a comprehensive direct view of the conformational response of SERT upon binding both biologically relevant substrate/ions and ligands of pharmaceutical interest, thus advancing our understanding of the structure-function relationship in SERT.

U2 - 10.1038/s41467-019-09675-z

DO - 10.1038/s41467-019-09675-z

M3 - Journal article

C2 - 30976000

SN - 2041-1723

VL - 10

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 1687

ER -

Conformational dynamics of the human serotonin transporter during substrate and drug binding

Abstract

Access to Document

Fingerprint

Cite this